In cases with a typical immunophenotype, a panel that includes CD19, CD5, CD20, CD23, and kappa and lambda light chain renders the diagnosis; however, larger panels are often used to further support the diagnosis and allow the differentiation with other CD5 positive lymphoproliferative disorders [4]. This evidence concerns the gene CD19 and lymphoproliferative syndrome.